Comparison of the Effectiveness of Walking Back Exercises and Rebound Therapy in Cerebral Palsy Rehabilitation
NCT ID: NCT04694118
Last Updated: 2021-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2021-01-04
2021-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To investigate the effect of walking back exercises and rebound therapy on muscle strength, functionality, balance and aerobic capacity in children with CP Implication for rehabilitation:Determining the effects of rehabilitative interventions (back and forth walking exercises and rebound therapy) to be applied in children with CP with objective measurement methods (muscle US, tetrax balance system) and evaluating the effects of the results on functionality and respiratory parameters
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Trunk-Focused Rehabilitation on Spinal Mobility, Trunk Control, and Hand Functions in Cerebral Palsy
NCT06781047
Effect of Multidimensional Trunk Training in Children With Cerebral Palsy
NCT07034872
The Effect of Treadmill Back Walking Training on Balance and Function in Cerebral Palsy
NCT04136678
Effects of Different Focuses of Attention on Walking and Balance in Children With Cerebral Palsy
NCT06170814
Investigation of the Effect of Constraint Induced Movement Therapy Applied to the Lower Extremity on Lower Extremity Functions in Individuals With Unilateral Cerebral Palsy
NCT06753812
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Being diagnosed with SP To be in the age range of 6-15 years, where effective communication can be provided in evaluation and treatment processes and when walking begins to mature Having adequate communication skills Being on level I or level II according to GMFM No impairment in visual functions in terms of not affecting postural control responses, Children with family consent
Study design:
Application of the evaluation methods specified at the beginning of the study to all 30 patients with CP who were randomly divided into 2 groups.
Re-evaluations were planned 8 weeks after the first evaluation of all cases who were continuing with structured neurodevelopmental treatment programs. In addition to the ongoing structured neurodevelopmental treatment programs; Group 1: 12 weeks / 3 days 20 minutes walking back exercises on normal ground, Group 2: Rebound therapy exercises, which are arranged according to the functional levels of the cases, will be applied in 12 weeks / 3 days for 20 minutes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
15 hemiparetic cerebral palsy,walking back group
GMFM I or II degreed 6-15 age range hemiparetic cerebral palsy
rebound therapy
3 days a week in 12 weeks
15 hemiparetic cerebral palsy,rebound therapy group
GMFM I or II degreed 6-15 age range hemiparetic cerebral palsy
rebound therapy
3 days a week in 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rebound therapy
3 days a week in 12 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Years
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Medipol University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ulkuatasoy2017
Msc.physiotherapist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ulku atasoy, msc.pt
Role: PRINCIPAL_INVESTIGATOR
PhD student
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Umran medical center
Istanbul, Uskudar, Turkey (Türkiye)
Ulku Atasoy
Istanbul, Ümraniye, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10840098-604.01.01-E.66352
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.